Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Health Behaviour Change

- PMLiVE

The brand model – time for change?

Is it time to tune more into emotional decision-making, letting go of a strict formulaic approach?

- PMLiVE

Sharing ideas to improve care for cancer patients – part 2

Quality in Care (QiC) Excellence in Oncology is a tri-partite programme recognising, rewarding and disseminating good practice in cancer management, education and patient care throughout the UK.

- PMLiVE

Sharing ideas to improve care for cancer patients – part 1

Quality in Care (QiC) Excellence in Oncology is a tri-partite programme recognising, rewarding and disseminating good practice in cancer management, education and patient care throughout the UK.

- PMLiVE

Avanir to co-promote Merck’s diabetes drugs in the US

Will market Januvia and Janumet to care homes

- PMLiVE

ViiV gets US nod for HIV drug dolutegravir

GSK and Pfizer joint venture on course for first drug launch

UK flag

UK sets aside £124m for health research projects

National Institute for Health Research to aims to revolutionise care

InnoPharma appoints Deborah DuFresne as VP

Will head strategic portfolio selection and management

- PMLiVE

Vical’s cancer immunotherapy fails in late-stage trial

Allovectin no better than standard chemotherapy

Pharma deals during July 2013

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

Deal Watch table for July 2013

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

Roche - Basel

Roche’s Erivedge authorised in UK

Available for skin cancer patients through Cancer Drugs Fund

- PMLiVE

Malaria vaccine gives “unprecedented” results

Able to protect 12 out of 15 people in phase I trial

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links